{"entity":{"type":"insider","cik":"0001802653","url":"/insider/0001802653","json_url":"/insider/0001802653.json","name":"Mitchell Stephen Ray","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2021-06-17","last":"2025-06-16","span_basis":"filed_date"},"name_variants":[{"name":"Mitchell Stephen Ray","source":"filing","n_filings":6,"first_seen":"2021-06-17","last_seen":"2025-06-16"}],"transactions":[{"id":5158905,"accession":"0000950170-25-087025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-087025","line_url":"/filing/0000950170-25-087025#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001802653","owner_name":"Mitchell Stephen Ray","owner_display_name":"Mitchell Stephen Ray","owner_url":"/insider/0001802653","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":4.59,"price_display":"4.59","price_state":"stated","total_value":32130.0,"total_display":"32,130.00","total_whole":"32,130","shares_owned_after":97082.0,"shares_owned_after_display":"97,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-16","scope":"insider"},{"id":2181513,"accession":"0000950170-24-128115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-128115","line_url":"/filing/0000950170-24-128115#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001802653","owner_name":"Mitchell Stephen Ray","owner_display_name":"Mitchell Stephen Ray","owner_url":"/insider/0001802653","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":5.1726,"price_display":"5.17","price_state":"stated","total_value":25863.0,"total_display":"25,863.00","total_whole":"25,863","shares_owned_after":44857.0,"shares_owned_after_display":"44,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-14","filed_date":"2024-11-18","scope":"insider"},{"id":7973163,"accession":"0001209191-23-045447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045447","line_url":"/filing/0001209191-23-045447#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001802653","owner_name":"Mitchell Stephen Ray","owner_display_name":"Mitchell Stephen Ray","owner_url":"/insider/0001802653","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":6.0537,"price_display":"6.05","price_state":"stated","total_value":39349.05,"total_display":"39,349.05","total_whole":"39,349","shares_owned_after":29328.0,"shares_owned_after_display":"29,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-11","scope":"insider"},{"id":6573594,"accession":"0001209191-22-036835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-036835","line_url":"/filing/0001209191-22-036835#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001802653","owner_name":"Mitchell Stephen Ray","owner_display_name":"Mitchell Stephen Ray","owner_url":"/insider/0001802653","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":9.4789,"price_display":"9.48","price_state":"stated","total_value":25593.03,"total_display":"25,593.03","total_whole":"25,593","shares_owned_after":6515.0,"shares_owned_after_display":"6,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-14","scope":"insider"},{"id":4287005,"accession":"0001209191-21-055685","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-055685","line_url":"/filing/0001209191-21-055685#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001802653","owner_name":"Mitchell Stephen Ray","owner_display_name":"Mitchell Stephen Ray","owner_url":"/insider/0001802653","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19109.0,"shares_display":"19,109","price_per_share":16.7448,"price_display":"16.74","price_state":"stated","total_value":319976.3832,"total_display":"319,976.38","total_whole":"319,976","shares_owned_after":9215.0,"shares_owned_after_display":"9,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-09","filed_date":"2021-09-13","scope":"insider"},{"id":4622048,"accession":"0001209191-21-041496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-041496","line_url":"/filing/0001209191-21-041496#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001802653","owner_name":"Mitchell Stephen Ray","owner_display_name":"Mitchell Stephen Ray","owner_url":"/insider/0001802653","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.4244,"price_display":"19.42","price_state":"stated","total_value":97122.0,"total_display":"97,122.00","total_whole":"97,122","shares_owned_after":9215.0,"shares_owned_after_display":"9,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Director","n_filings":6,"first_seen":"2021-06-17","last_seen":"2025-06-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001802653","retrieved_at":"2026-08-23T05:04:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}